News
Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...
In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...
StockStory.org on MSN11h
5 Must-Read Analyst Questions From Illumina’s Q1 Earnings CallIllumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...
The firm hopes that ETX-636's dual mechanism inhibiting mutant PI3Kα will give it an edge over competing products on the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results